Microgestin Fe 1.5/30
Product Images NDC 53002-3567

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Microgestin Fe 1.5/30 (NDC 53002-3567). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

Chemical structure diagrams showing the active ingredients Norethindrone Acetate and Ethinyl Estradiol, typically used in the oral contraceptive Microgestin Fe 1.5/30 by RPK Pharmaceuticals, Inc.*

FDA Label Image

2 (Image 02)

A table titled 'Lowest Expected and Typical Failure Rates During the First Year of Continuous Use of a Method' showing percentages of women experiencing unintended pregnancy within the first year using various contraceptive methods. Methods listed include oral contraceptives, diaphragm, spermicides, vaginal sponge, implants, injections, IUDs, condoms, cervical cap, periodic abstinence, withdrawal, and sterilization, with columns for lowest expected and typical failure rates.*

FDA Label Image

3 (Image 03)

A text panel warning that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, particularly in women over 35 years old and heavy smokers (15 or more cigarettes per day). It advises women using oral contraceptives not to smoke.*

FDA Label Image

4 (Image 04)

A bar chart titled 'Table II Circulatory Disease Mortality Rates per 100,000 Woman Years by Age, Smoking Status and Oral Contraceptive Use.' It compares mortality rates among different age groups (15-24, 25-34, 35-44, 45+) with categories for ever-users and controls, subdivided by smoking status. The mortality rate is shown on the vertical axis, with the highest rate in the 45+ ever-smoker user group.*

FDA Label Image

5 (Image 05)

A table presenting the annual number of birth-related or method-related deaths per 100,000 nonsterile women by fertility control method according to age groups (15-19, 20-24, 25-29, 30-34, 35-39, 40-44). The methods listed include no fertility control, oral contraceptives for non-smokers and smokers, IUD, condom, diaphragm/spermicide, and periodic abstinence, with death counts varying by age and method.*

FDA Label Image

6 (Image 06)

A warning text panel indicating that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. The risk rises with age and heavy smoking (15 or more cigarettes per day), particularly in women over 35 years of age, and advises women using oral contraceptives not to smoke.*

FDA Label Image

7 (Image 07)

An instructional diagram for Microgestin Fe 1.5/30 tablets showing a pill pack with 21 yellow active pills for weeks 1-3 and brown inactive pills for week 4. It includes directions to take pills from left to right each week and guidance on starting based on the day of the week, with a hand peeling back a day label sticker.*

FDA Label Image

8 (Image 08)

Warning label text indicating that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, with risk increasing with age and heavier smoking, particularly marked in women over 35 years, advising women using oral contraceptives not to smoke.*

FDA Label Image

9 (Image 09)

A warning text panel stating that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. It notes that this risk is higher with age and heavy smoking (15 or more cigarettes per day) and is particularly significant in women over 35 years of age. The text strongly advises women using oral contraceptives not to smoke.*

FDA Label Image

10 (Image 10)

A data table showing the annual number of birth-related or method-related deaths per 100,000 nonsterile women by fertility control method and age group. The table lists fertility control methods including no fertility control, oral contraceptives (non-smoker and smoker), IUD, condom, diaphragm/spermicide, and periodic abstinence across age ranges 15-19, 20-24, 25-29, 30-34, 35-39, and 40-44. It distinguishes birth-related from method-related deaths with footnotes.*

FDA Label Image

11 (Image 11)

An instructional diagram showing how to take Microgestin Fe 1.5/30 pills, indicating 21 yellow active pills for weeks 1, 2, and 3, followed by brown inactive pills for week 4. The image includes a pill pack with days of the week labeled and a hand peeling a day label sticker to align the start day for pill intake, with arrows showing the direction to take pills from left to right each week.*

FDA Label Image

12 (Image 12)

FDA Label Image

Label Image (Lbl530023567)

Microgestin Fe 1.5/30 film-coated tablets 28-count blister pack label from RPK Pharmaceuticals, Inc. The label indicates a 1-month supply with dosing instructions to take 1 tablet daily as directed. It includes patient and prescriber information fields, barcode, and NDC 53002-3567. The package is designed for oral contraceptive use with iron supplement tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.